MediWoundvsSherwin-Williams

MDWD and SHW stock compared: price, dividend, valuation and results, from SEC filings.

SHW

The Sherwin-Williams Company

$339.74

Value $84.2B

-0.03%
SHW's page

MediWound (MDWD) has a market value of $174M and Sherwin-Williams (SHW) $84.2B. Over the last year, with dividends, MDWD moved -23.9% and SHW +4.0%. Dividend yield: MDWD none, SHW 0.94%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MDWD$174M

    SHW$84.2B

    SHW is 483 times MDWD

  • Revenue, 12 months

    MDWD$17M

    SHW$24.9B

    SHW is 1,469 times MDWD

  • Net income, 12 months

    MDWD-$24M

    SHW$2.7B

  • Operating margin

    MDWD-149.0%

    SHW–

  • ROIC

    MDWD-45.8%

    SHW17.7%

    63.4 points apart

  • P/E

    MDWD–

    SHW31.5

  • Dividend yield

    MDWD0.0%

    SHW0.9%

    0.9 points apart

  • 5-year return

    MDWD-32.4%

    SHW+7.1%

    39.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MDWD-32.4%

SHW+7.1%

507510012520222023202420252026
Returns by period
PeriodMDWDWith dividendsSHWWith dividends
1 year since November 19, 2025-23.9%Price -23.9%+4.0%Price +3.0%
3 years since November 20, 2023+58.8%+16.7% a yearPrice +58.8%+27.8%+8.5% a yearPrice +24.4%
5 years since November 19, 2021-32.4%-7.5% a yearPrice -32.4%+7.1%+1.4% a yearPrice +2.3%
10 years since November 22, 2016-63.4%-9.6% a yearPrice -63.4%+315.1%+15.3% a yearPrice +279.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MDWDMediWoundSHWSherwin-Williams

Valuation

MDWDSHW
Valuation
Price$13.59$339.74
Market value$174M$84.2B
Enterprise value (EV)–$94.2B
P/E–31.5
P/E, 5-year median–32.2
P/B4.021.2
EV/EBIT–27.0
Free cash flow yield–3.7%

Results and growth

MDWDSHW
Results and growth
Revenue, 12 months$17M$24.9B
Net income, 12 months-$24M$2.7B
Free cash flow, 12 months-$22M$3.1B
Earnings per share, 12 months-$2.10$10.88
Revenue growth, year on year-16.1%2.1%
Revenue growth a year, past-4.9%over 5 years+5.1%over 5 years
EPS growth a year, past–+6.9%over 5 years

Margins and returns on capital

MDWDSHW
Margins and returns on capital
Gross margin19.2%48.6%
Operating margin-149.0%–
Net margin-140.8%10.7%
ROIC-45.8%17.7%
ROE-54.7%62.9%

Balance sheet

MDWDSHW
Balance sheet
Cash$4.8M$264M
Total debt–$12.5B
Net debt / EBITDA–2.6
Interest cover-10.3×6.5×

Dividends and buybacks

MDWDSHW
Dividends and buybacks
Dividend yield–0.9%
Dividend per share, 12 months–$3.20
Dividend growth a year, past–+12.1%over 5 years
Buyback yield–2.0%
Shareholder yield–2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MDWD or SHW

Didn't find what you were looking for?

Ask us
Which is bigger, MediWound or Sherwin-Williams?

By market value, Sherwin-Williams ($84.2B) is about 482.6 times MediWound ($174M), at today's prices.

How did MDWD and SHW stock do over the last 10 years?

Since November 22, 2016, MDWD's price moved -63.4% and SHW's +279.2%. With dividends: MDWD -63.4% (-9.6% a year), SHW +315.1% (+15.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, MDWD or SHW?

The dividend yield at today's price is none for MediWound and 0.94% for Sherwin-Williams. Over the last twelve months they paid – and $3.20 per share.

Which has the higher profit margins, MediWound or Sherwin-Williams?

Over the last twelve months, the net margin was -140.8% for MediWound and 10.7% for Sherwin-Williams, and the operating margin -149.0% and –. Revenue was $17M and $24.9B.

Which is the better investment, MediWound or Sherwin-Williams?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.